Outcomes16

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 16 of 16

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Proportion of Participants That Ovulate During Month 3	3 months	One participant in the standard dose arm was withdrawn at week 1 of the study due to pregnancy.	Participants	COUNT_OF_PARTICIPANTS
PRIMARY	Proportion of Participants That Ovulate During Month 6	6 months	One participant in the standard dose arm was withdrawn at week 1 of the study due to pregnancy.	Participants	COUNT_OF_PARTICIPANTS
PRIMARY	Proportion of Participants That Ovulate During Month 12	12 months	One participant in the standard dose arm was withdrawn at week 1 of the study due to pregnancy, and one was withdrawn at week 45 due to a mental health condition.	Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Proportion of Cervical Mucus Scores Greater Than 10	12 months	Evaluable cervical mucus samples collected from participants over 48 weeks of etonogestrel implant use. One participant in the standard dose arm was withdrawn at week 1 of the study due to pregnancy.	Cervical mucus samples	COUNT_OF_UNITS
SECONDARY	Median Efavirenz Concentration at Enrollment	Day 0	Efavirenz concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week.	µg/mL	MEDIAN
SECONDARY	Median Efavirenz Concentration at Week 4	4 weeks	Efavirenz concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 and 1 participant who missed the 4-week visit.	µg/mL	MEDIAN
SECONDARY	Median Efavirenz Concentration at Week 12	12 weeks	Efavirenz concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week and 1 participant who missed the 12-week visit.	µg/mL	MEDIAN
SECONDARY	Median Efavirenz Concentration at Week 24	24 weeks	Efavirenz concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week.	µg/mL	MEDIAN
SECONDARY	Median Efavirenz Concentration at Week 36	36 weeks	Efavirenz concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week.	µg/mL	MEDIAN
SECONDARY	Median Efavirenz Concentration at Week 48	48 weeks	Efavirenz concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week and 1 participant who missed the 48-week visit.	µg/mL	MEDIAN
SECONDARY	Median Etonogestrel Concentration at Week 1	1 week	Etonogestrel concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week.	pg/mL	MEDIAN
SECONDARY	Median Etonogestrel Concentration at Week 4	4 weeks	Etonogestrel concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week and 1 participant who missed the 4-week visit.	pg/mL	MEDIAN
SECONDARY	Median Etonogestrel Concentration at Week 12	12 weeks	Etonogestrel concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week and 1 participant who missed the 12-week visit.	pg/mL	MEDIAN
SECONDARY	Median Etonogestrel Concentration at Week 24	24 weeks	Etonogestrel concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week.	pg/mL	MEDIAN
SECONDARY	Median Etonogestrel Concentration at Week 36	36 weeks	Etonogestrel concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week.	pg/mL	MEDIAN
SECONDARY	Median Etonogestrel Concentration at Week 48	48 weeks	Etonogestrel concentration not evaluated for 1 participant who was discontinued due to pregnancy at 1 week and 1 participant who missed the 48-week visit.	pg/mL	MEDIAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03282799/outcomes

API reference For AI assistants